U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
198451198451Effect of Vaccination on Turnover of Lamivudine (3TC) Sensitive and Resistant Virus Populations in HIV-1-Infected IndividualsWithdrawnNo Results AvailableHIV InfectionsBiological: Influenza Virus Vaccine|Biological: Pneumococcal Vaccine, Polyvalent (23-valent)|Drug: Lamivudinehttps://ClinicalTrials.gov/show/NCT00001080
198452198452A Study of Megestrol Acetate Alone or in Combination With Testosterone Enanthate Drug in the Treatment of HIV-Associated Weight LossCompletedNo Results AvailableHIV Infections|HIV Wasting SyndromeDrug: Testosterone enanthate|Drug: Megestrol acetatehttps://ClinicalTrials.gov/show/NCT00001079
198453198453A Study on the Rate of Opportunistic (AIDS-Related) Infections Among HIV-Positive Children Who Have Stopped Taking Their OI Preventive MedicationsCompletedNo Results AvailableHIV InfectionsBiological: Hepatitis A Vaccine (Inactivated)https://ClinicalTrials.gov/show/NCT00001078
198454198454A Comparison of Two Caloric Supplements in the Prevention of Weight Loss in Patients With AIDS Who Take Daily Multivitamin and Mineral SupplementsCompletedNo Results AvailableHIV Infections|HIV Wasting SyndromeDietary Supplement: Multivitamin and mineral supplements|Dietary Supplement: Peptamen|Dietary Supplement: NuBasicshttps://ClinicalTrials.gov/show/NCT00001077
198455198455A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205) and HIV-1 SF-2 rgp120 in HIV-1 Uninfected Volunteers to Evaluate Accelerated Vaccine SchedulesCompletedNo Results AvailableHIV InfectionsBiological: ALVAC-HIV MN120TMG (vCP205)|Biological: ALVAC-RG Rabies Glycoprotein (vCP65)|Biological: rgp120/HIV-1 SF-2https://ClinicalTrials.gov/show/NCT00001076
198456198456The Effectiveness of Ritonavir Plus Zidovudine Plus Lamivudine in HIV-Infected PatientsCompletedNo Results AvailableHIV InfectionsDrug: Ritonavir|Drug: Lamivudine|Drug: Zidovudinehttps://ClinicalTrials.gov/show/NCT00001075
198457198457The Safety and Effectiveness of Hydroxyurea and ddI Used Individually or Together in HIV-Infected PatientsCompletedNo Results AvailableHIV InfectionsDrug: Hydroxyurea|Drug: Didanosinehttps://ClinicalTrials.gov/show/NCT00001074
198458198458Safety and Effectiveness of Giving Isotretinoin to HIV-Infected Women to Treat Cervical TumorsCompletedNo Results AvailableHIV Infections|Cervix, DysplasiaDrug: Isotretinoinhttps://ClinicalTrials.gov/show/NCT00001073
198459198459A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP300 and HIV-1 SF-2 rgp120 in HIV-1 Uninfected Adult VolunteersCompletedNo Results AvailableHIV InfectionsBiological: ALVAC-HIV MN120TMGNP (vCP300)|Biological: ALVAC-RG Rabies Glycoprotein (vCP65)|Biological: rgp120/HIV-1 SF-2https://ClinicalTrials.gov/show/NCT00001072
198460198460A Study of Stem Cells and FilgrastimCompletedNo Results AvailableHIV InfectionsDrug: Filgrastimhttps://ClinicalTrials.gov/show/NCT00001071
198461198461The Safety and Effectiveness of Different Doses of Vitamin C in HIV-Infected PatientsWithdrawnNo Results AvailableHIV InfectionsDrug: Oral Vitamin Chttps://ClinicalTrials.gov/show/NCT00001070
198462198462A Study of Two Methods of Determining When to Begin or Change Anti-HIV TreatmentTerminatedNo Results AvailableHIV Infectionshttps://ClinicalTrials.gov/show/NCT00001069
198463198463A Study of Disease Progression and Anti-HIV TreatmentsCompletedNo Results AvailableHIV InfectionsDrug: Lamivudinehttps://ClinicalTrials.gov/show/NCT00001068
198464198464The Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Never Used Anti-HIV DrugsCompletedNo Results AvailableHIV InfectionsDrug: Lamivudine|Drug: Stavudine|Drug: Zidovudinehttps://ClinicalTrials.gov/show/NCT00001067
198465198465A Comparison of Zidovudine Plus Lamivudine Versus ddI Used Alone or in Combination With Zidovudine in HIV-1 Infected ChildrenCompletedNo Results AvailableHIV InfectionsDrug: Lamivudine|Drug: Zidovudine|Drug: Didanosinehttps://ClinicalTrials.gov/show/NCT00001066
198466198466A Study of Amphotericin B in the Treatment of Fungal Infections of the Mouth in HIV-Infected Patients Who Have Not Had Success With FluconazoleCompletedNo Results AvailableCandidiasis, Oral|HIV InfectionsDrug: Amphotericin Bhttps://ClinicalTrials.gov/show/NCT00001065
198467198467A Pilot Study of Immunization With HIV-1 Antigen Pulsed Allogenic Dendritic Cells in HIV-Infected Asymptomatic Patients With CD4+ T Cells > 350 Cells/mm3TerminatedNo Results AvailableHIV InfectionsDrug: Allogenic Dendritic Cellshttps://ClinicalTrials.gov/show/NCT00001064
198468198468The Effectiveness of Three Drug Combinations in HIV-Infected Patients Who Have Taken Zidovudine for More Than 12 WeeksCompletedNo Results AvailableHIV InfectionsDrug: Stavudine|Drug: Zidovudine|Drug: Didanosinehttps://ClinicalTrials.gov/show/NCT00001063
198469198469A Study of Ganciclovir in the Treatment of Cytomegalovirus of the EyesCompletedNo Results AvailableCytomegalovirus Retinitis|HIV InfectionsDrug: Ganciclovirhttps://ClinicalTrials.gov/show/NCT00001062
198470198470Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDSCompletedNo Results AvailableCytomegalovirus Retinitis|HIV InfectionsDrug: Sevirumab|Drug: Foscarnet sodium|Drug: Ganciclovirhttps://ClinicalTrials.gov/show/NCT00001061
198471198471A Phase I Trial of HIV-1 C4-V3 Polyvalent Peptide Vaccine in HIV-1 Infected PersonsCompletedNo Results AvailableHIV InfectionsBiological: HIV-1 C4-V3 Polyvalent Peptide Vaccinehttps://ClinicalTrials.gov/show/NCT00001060
198472198472Comparison of Liposomal Doxorubicin Used Alone or in Combination With Bleomycin Plus Vincristine in the Treatment of Kaposi's Sarcoma in Patients With AIDSCompletedNo Results AvailableSarcoma, Kaposi|HIV InfectionsDrug: Doxorubicin hydrochloride (liposomal)|Drug: Filgrastim|Drug: Bleomycin sulfate|Drug: Vincristine sulfatehttps://ClinicalTrials.gov/show/NCT00001059
198473198473A Comparison of Three Drug Combinations Containing Clarithromycin in the Treatment of Mycobacterium Avium Complex (MAC) Disease in Patients With AIDSCompletedNo Results AvailableMycobacterium Avium-intracellulare Infection|HIV InfectionsDrug: Indinavir sulfate|Drug: Ritonavir|Drug: Ethambutol hydrochloride|Drug: Clarithromycin|Drug: Rifabutinhttps://ClinicalTrials.gov/show/NCT00001058
198474198474The Effectiveness of Two Anti-HIV Treatments in HIV-Infected PatientsCompletedNo Results AvailableHIV InfectionsDrug: Zidovudine|Drug: Didanosinehttps://ClinicalTrials.gov/show/NCT00001057
198475198475A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia Derived HIV-1 Recombinant Envelope Glycoprotein (gp160) of Human Immunodeficiency Virus: Evaluation of a 200-mcg DoseCompletedNo Results AvailableHIV InfectionsBiological: gp160 Vaccine (Immuno-AG)https://ClinicalTrials.gov/show/NCT00001056
198476198476A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205) in HIV-1 Uninfected Adult VolunteersCompletedNo Results AvailableHIV InfectionsBiological: ALVAC-HIV MN120TMG (vCP205)|Biological: ALVAC-RG Rabies Glycoprotein (vCP65)|Biological: rgp120/HIV-1 SF-2https://ClinicalTrials.gov/show/NCT00001055
198477198477The Safety and Effectiveness of Valacyclovir HCl in the Treatment of Herpes Simplex or Varicella/Zoster Infections in HIV-1 Infected ChildrenWithdrawnNo Results AvailableHerpes Simplex|HIV Infections|ChickenpoxDrug: Valacyclovir hydrochloridehttps://ClinicalTrials.gov/show/NCT00001054
198478198478A Phase I Safety and Immunogenicity Study of HIV p17/p24:Ty-VLP in HIV-1 Seronegative SubjectsCompletedNo Results AvailableHIV InfectionsBiological: HIV p17/p24:Ty-VLP|Biological: Aluminum hydroxidehttps://ClinicalTrials.gov/show/NCT00001053
198479198479A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of MN Recombinant Soluble gp120/HIV-1 (rsgp120/HIV-1) (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy ACompletedNo Results AvailableHIV InfectionsBiological: Aluminum hydroxide|Biological: QS-21|Biological: rgp120/HIV-1MNhttps://ClinicalTrials.gov/show/NCT00001052
198480198480Study of Women Who Have AIDSTerminatedNo Results AvailableHIV Infectionshttps://ClinicalTrials.gov/show/NCT00001050

* Görseller ve İçerik tekif hakkına sahip olabilir